UNITAID’s Market Approach in HIV Diagnostics Brenda Waning International AIDS Society 18 July, 2011 Rome.

Slides:



Advertisements
Similar presentations
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Advertisements

Consultative expert working group - proposals Barcelona
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
 Capacity Development; National Systems / Global Fund Summary of the implementation capacities for National Programs and Global Fund Grants For HIV /TB.
UNITAID Innovative Financing Mechanism  Denis Broun Executive Director.
Pre Tender Meeting UNICEF Supply Division, December 2008 Rob Matthews UNICEF Vaccine Procurement for Developing Countries.
Family Innovation Fund Early Intervention for Children, Young People and Families Clare Burrell Head of Commissioning Vulnerable People.
PARIS 21 Meeting Ghana July Challenges in health information Health Metrics Network HMN Framework and profiling tool.
Almost 14 years ago all countries endorsed a set of 8 Millennium Development Goals (or MDGs). 3 of those 8 Goals focus on health – that being child mortality,
Overview of FANRPAN By Lindiwe Majele Sibanda
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Public health, innovation and intellectual property 1 |1 | WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Global Strategy and Plan.
UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.
Clermont-Ferrand, 11 May, 2011 Performance based funding Global Fund to fight AIDS, Tuberculosis and Malaria – progress and challenges Kirsi Viisainen,
1 New Funding Model Key features and implementation Inter-Agency Meeting 5-7 March 2014 Linda Mafu, Head Political and Civil Society Advocacy Department,
Increasing Country & Community Involvement in Global Health Policy Processes? The Case of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Carlos.
Treatment Optimization in Latin America and the Caribbean: How can the GF contribute?
Update on the California Dairy Future Task Force and moving forward December 5, 2012 CONFIDENTIAL AND PROPRIETARY Any use of this material without specific.
One SADC, One Vision, One Way Working Together Towards MDG 6: SADC’s Common Vision Hon. Benedict Xaba, Minister of Health of Swaziland International AIDS.
‘More Than Just Lip Service: Scaling up sex work initiatives’ Making the Money Matter: Support for sex worker initiatives through the Global Fund for HIV,
The Role of the School in Health, Learning and Development in Low Income Countries Lesley Drake, Coordinator.
WHO Global Coordination Mechanism on the prevention and control of NCDs (WHO GCM/NCD) Informal information session (briefing) for Member States Geneva,
Country Ownership of National HIV & AIDS Response: A Private Sector Perspective Country Ownership of National HIV & AIDS Response: A Private Sector Perspective.
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
The Global Fund- structure, function and evolution February 18, 2008.
Prevention and Remediation in Selected Industrial Sectors, June 2005, Ottawa NATO’s Scientific Programme Thomas Strassburger Ottawa, Canada NATO’s.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Federation of Kenya Employers responds to HIV: Clustered HIV and AIDS Enterprise Networks Working It Out: HIV and Workplace Isaac Kiema-
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
What is HMN? Global partnership founded on the premise that better health information means better decisions and better health Partners reflect wide.
1 Domestic Financing for Health Parliamentarian Round Table March 2014,Joburg, SA Linda Mafu, Head Political Advocacy and Civil Society Department,
UNITAID Matching Innovation and Sustainability: An Innovative Mechanism for Scaling-up Treatment for HIV/AIDS, TB and Malaria Jorge Bermudez, Executive.
Quality Assurance for pharmaceutical products in international procurement Approach of major donors and procurers Core presentation prepared by Sophie.
1 Introduction to the Clinton Foundation HIV/AIDS Initiative 12 July 2007 Africa Recruit.
Warszawa 18 luty th Framework Programme NMP - 2nd Calls Integrated Projects for SMEs Hervé Péro, Christophe Lesniak DG Research.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Donors, prize funds and patent pools. KEI & UNU- MERIT Maastricht Workshop on Medical Innovation Prizes January 28th-29th 2008 Michelle Childs, Head of.
Working Draft - Last Modified :21:46 Printed UNITAID action plan - pediatric TB 0 “Securing timely access to quality, affordable TB drugs”
Preliminary classification of proposals by the CEWG Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative Expert Working.
OVERVIEW OF MACROECONOMIC & HEALTH KEY POINTS FROM THE OCTOBER 2003 GLOBAL CONSULTATION Briefing for Permanent Mission Representatives.
CAI-Asia is building an air quality management community in Asia Investment Implications of the Action Plan Sustainable Urban.
TB/HIV Working Group Working Groups Collaboration to Raise and Enhance Awareness of TB/HIV Colleen Daniels Technical Officer TB/HIV Advocacy & Communications.
Update to IPC 10 December 2015 UNITAID's transformation.
Efficiency, Effectiveness, and Financial Sustainability: The Importance of Country Ownership Dr Bernhard Schwartländer UNAIDS.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
PEPFAR The Global Fund and PEPFAR: Strategic Collaboration for Greater Impact Mark Edington, Director, Grants Management, Global Fund Julia Martin, Chief.
Achievements and impacts of WHO prequalification to date MSF perspective Carine Werder MSF international pharmacist coordinator Geneva, 11 th February.
Page 0 UNITAID’s Strategic Approach to HIV Diagnostics  Washington DC 22 July, 2012 XIX International AIDS Conference Brenda Waning.
The WHO Prequalification of Medicines Program - Introduction Tony Gould Manager, Prequalification of Medicines Program WHO.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Kerstin Ödman Chair of the Strategy Working Group Ad hoc NDPHS Strategy Working Group Report for the NDPHS committee of Senior Representatives Riga,
BioEnergy Sustaining The Future 2 BESTF2 Briefing Event 11 th December 2013 Dr Megan Cooper, BESTF co-ordinator.
1 Facilitating global health delivery through operations research Center for Strategic HIV Operations Research (CSHOR) Deborah Cotton MD, MPH Chief Medical.
Burden of Disease Research Unit (BOD) Towards a National Procedure Coding Standard for South Africa Lyn Hanmer Health Informatics R&D Co-ordination (HIRD)
UNITAID actions and main achievements Investing in the quality of medicines XVII International AIDS Conference Satellite Forum WHO – Essential Medicines.
Global Fund Work on HIV/SRH Linkages 09 March 2015 Olga Bornemisza New York, USA IAWG Meeting on HIV/SRH Linkages.
SADC Medicines Database (SMD)
EMR Consultation, HRH Observatory, Tunis, September 2010
Procurement and Supply Management Policies
Proposal Development Overview by Proposal Development Committee
International Financing Institutions (IFI) Engagement
Overview of the Strategic Framework Guda Alemayehu September 29,2016 Dakar We are now over 300 members.
Access to Essential Medicines
Millennium Development Goals (MDGs)
Every Mother, Every Child: Closing the Gaps in HIV Management
National Skills Development Plan (NSDP) Skills Planning and Research
How are programmes specifically designed using collected data?
Presentation transcript:

UNITAID’s Market Approach in HIV Diagnostics Brenda Waning International AIDS Society 18 July, 2011 Rome

Presentation Outline Overview of UNITAID Description of UNITAID’s market approach to improve public health Summary of UNITAID’s current and planned activities in the area of HIV diagnostics

UNITAID: a WHO Partnership moving markets Partners Working towards the common goal of expanding access to health Est. 2006: Innovative finance mechanism based largely on air tax levies from north & south Geneva-based secretariat: no in-country offices – work with partners Work exclusively through markets to improve access to medicines, diagnostics and preventative items for HIV/AIDS, tuberculosis, and malaria

UNITAID Goal UNITAID aims to promote “healthy”, dynamic market conditions whereby manufacturers have incentives to invest and innovate, while at the same time supply quality public health products at sustainable, affordable prices and in acceptable formulations that enable the maximum number of people to access them.

How UNITAID intervenes UNITAID’s role depends upon the particular circumstances in a given market: Market catalyst: identifying and facilitating adoption and uptake of new and/or superior public health products; Market creator: providing incentives for manufacturers to produce otherwise unattractive products with low demand that yield little profit but substantial public health benefit to those in need; and Market “fixer”: addressing severe market inefficiencies (e.g. grossly inaccurate demand forecasts and excessive transaction costs) that contribute to low access to quality- assured public health products.

UNITAID Market impact framework

UNITAID Intervention example: 2 nd line ARV market Partners: Clinton Health Access Initiative (CHAI), WHO Prequalification Programme for Medicines

UNITAID current & planned activities in HIV diagnostics (1)) Landscape analyses map the landscape (disease, technology, market) for diagnostics across the 3 diseases update every 6 months internal value - inform priorities, decision making external value: public good to other organizations Call for letters of intent (and then proposals) for projects to increase access to diagnostics in the 3 disease areas expected launch: last week of July 2011 To be posted on website:

HIV Diagnostics Landscape Released 1 June

UNITAID current & planned activities in HIV diagnostics (2) Create mechanisms to compare potential projects against UNITAID prioritization criteria: Market impact Public health impact Innovation Value for money Provide all inputs (landscapes, prioritization analyses) to UNITAID technical & decision-making bodies Continue dialogue with other organizations this session: dissemination & feedback

Thank you Contact Information: Brenda Waning Coordinator, Market Dynamics UNITAID